Viewing data from:

GRIFULVIN V

ANDA

GRISEOFULVIN, MICROSIZE | A062483 | VALEANT PHARMACEUTICALS LUXEMBOURG SARL

1 strength0 unique patents0 unique exclusivities

Products (1)

#001 — 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

0 patents0 exclusivities▴

SUSPENSION;ORAL | Approved: Jan 26, 1984

No patent or exclusivity listings for this strength.